首页> 外国专利> ENO1 DIAGNOSTIC METHODS FOR PROGNOSIS OF NON-SMALL-CELL LUNG CANCER USING ENO1 SNP

ENO1 DIAGNOSTIC METHODS FOR PROGNOSIS OF NON-SMALL-CELL LUNG CANCER USING ENO1 SNP

机译:ENO1 SNP诊断非小细胞肺癌的ENO1诊断方法

摘要

The present invention relates to the single nucleotide polymorphism of the ENO1 (enolase 1) gene for the prediction of the prognosis of non-small cell lung cancer (NSCLC). More specifically, the ENO1 gene uses SNP of rs2274971, The present invention relates to a method for diagnosing and predicting a prognosis affecting the survival result of cell lung cancer and its use. The prediction technique of lung cancer survival prognosis according to the present invention can increase the survival rate of lung cancer patients by easily evaluating the prognosis of patients with lung cancer and targeting the means and treatment for selecting and evaluating treatment methods.
机译:本发明涉及用于预测非小细胞肺癌(NSCLC)预后的ENO1(烯醇酶1)基因的单核苷酸多态性。更具体地,ENO1基因使用rs2274971的SNP。本发明涉及诊断和预测影响细胞肺癌的存活结果的预后的方法及其用途。通过容易地评估肺癌患者的预后并且针对选择和评估治疗方法的手段和治疗,根据本发明的肺癌生存预后的预测技术可以提高肺癌患者的生存率。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号